RecruitingNot ApplicableNCT06302751

A Mobile Application to Improve Postoperative Outcomes in Colorectal Cancer

An Electronic Remote Application to Improve the Postoperative Outcomes in Colorectal Cancer Patients: Single-center, Interventional Study


Sponsor

Istituto Clinico Humanitas

Enrollment

600 participants

Start Date

Feb 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The unplanned readmission rate after colorectal cancer surgery is still high, despite the implementation of enhanced recovery programs. The use of a mobile-based application for perioperative remote monitoring may improve the postoperative outcomes and reduce the unplanned postoperative readmissions.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients aged more than 18 years old.
  • Patients scheduled for elective curative colorectal resection, including right (or extended) colectomy, left colectomy, rectal resection (with or without ileostomy), total colectomy, recanalization, or multiple colon resection.
  • Patients willing to comply with the study procedures.
  • Proficient understanding of the Italian language

Exclusion Criteria5

  • Any condition that, in the opinion of the investigator, may interfere with the study procedures.
  • Patients scheduled for palliative surgery.
  • Patients with a planned elective intervention requiring urgent or emergent surgery will be withdrawn from the study.
  • Pregnant or breastfeeding women.
  • Inability to comply with the study procedures.

Interventions

DEVICECare 4 Today ® (Johnson and Johnson) mobile app

Care 4 Today ® (Johnson and Johnson) mobile app will cover the perioperative period spanning through the preoperative assessment day (approximately -seven to -one from surgery) to 30 days after surgery and will monitor the adherence to preoperative and postoperative recommendations.


Locations(1)

IRCCS Humanitas Research Hospital

Rozzano, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06302751


Related Trials